Trade
Natural Capsules share price
High risk
You have to be logged in to add this to Watchlist.- ₹214.55(-2.26%)July 8, 2025 15:47:32 PM IST
- NSE
- BSE
- Vol : 3.82K (NSE + BSE)Last 20 day avg : 6.24 K
Natural Capsules is trading -2.26% lower at Rs 214.55 as compared to its last closing price. Natural Capsules has been trading in the price range of 221.00 & 210.30. Natural Capsules has TTM P/E ratio 657.96 as compared to the sector P/E of 23.19.The company posted a net profit of 0.52 Crores in its last quarter.Listed peers of Natural Capsules include Gennex Laboratories (2.98%), Sanjivani Paranteral (0.99%), Natural Capsules (-2.26%).The Mutual Fund holding in Natural Capsules was at -% in . The MF holding has - from the last quarter. The FII holding in Natural Capsules was at -% in . The FII holding has - from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Key Metrics
Updated on Jul 08, 2025, 11:06 AM UTC
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- P/BLower than historical values0.97The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/EHigher than historical values781.39Price-to-earnings ratio based on trailing 12-month earnings
- Debt To EquityHigher than industry0.45The debt-to-equity ratio, indicating a company's financial leverage.
- Beta-Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- PEG Ratio-The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
Price range
Day Range
|
| ||||
52 week range
|
| ||||
Natural Capsules Financials
Financials
View allFinancials include key reports like the Profit & Loss Statement (P&L), Balance Sheet, and Cash Flow Statement, providing insights into a company's performance, financial health, and liquidity
- Income
- Balance Sheet
- Cash Flow
Loading...
Units in the chart are in crores
Insights
- Financial
- Valuation
Company is profitable- The company's revenue grew in March quarter by 11.81% from Rs 44.97 crore to Rs 40.22 crore, year-on-year
The company's profit declined by 45.96% year-on-year during the March quarter, dropping from Rs 0.96 crore to Rs 0.52 crore- The debt to equity of the company is higher than the industry median
- Earnings are insufficient to cover the interest expenses on outstanding debt
Natural Capsules Technical Analysis
Pivot Level - classic
Key price levels (support and resistance) calculated using the previous day's high, low, and close, aiding in technical analysis and trading decisions
- R1
- 230.08
- R2
- 239.57
- R3
- 246.28
Pivot223.37
- S1
- 213.88
- S2
- 207.17
- S3
- 197.68
Short Term
Considers price movement over the last 1-2 weeks
Not Available
Long Term
Considers price movement over the last 6 months
Not Available
- Very Bearish
- Bearish
- Neutral
- Very Bullish
- Bullish
Trends unavailable at the moment.
Natural Capsules Peers
Return Comparison
Peers Comparison
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Gennex Laboratories | Neutral | 12.80 | 2.98 | 291.13 | 15.96 | 1.52 | - | - |
| Sanjivani Paranteral | Moderately Bearish | 219.95 | 0.99 | 261.52 | 32.50 | 6.77 | - | 13.92 |
| Natural Capsules | Bearish | 214.55 | -2.26 | 221.26 | 998.23 | 0.97 | - | 24.65 |
| Alpa Laboratories | Neutral | 101.70 | - | 215.34 | 11.19 | 1.28 | - | - |
| Bafna Pharmaceuticals | Bullish | 85.43 | -1.57 | 202.03 | 51.17 | 2.51 | - | 16.54 |
Natural Capsules Shareholding
View AllShareholding Pattern
Breakdown of a company's ownership structure, showing stakes held by Promoters, Mutual Funds, FII(s) & Others.
Shareholding pattern for Natural Capsules is currently unavailable
Please check back later.
Shareholding Insights
- Promoter(s) holds a high stake in the company at 51.21%
- Promoter(s) have increased the stake in the company in last 12 months
- FIIs are not invested in this company
- Mutual Funds are not invested in this company.
Natural Capsules Corporate Actions
View all- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-05-29 | Audited Results |
| 2025-02-12 | Quarterly Results |
| 2024-11-12 | Quarterly Results |
| 2024-08-13 | Quarterly Results |
| 2024-07-26 | Preferential issue of shares |
About the company Natural Capsules
- IndustryBiotechnology & Drugs
- ISININE936B01015
- BSE Code524654
- NSE CodeNATCAPSUQ
Natural Capsules Limited is an India-based hard capsule shell manufacturer, specialized in manufacturing an array of capsules, including hard gelatin capsules, vegetarian capsules, and various specialty variants. The Company offers a diverse range of capsule products to both domestic and international markets, serving the pharmaceutical and nutraceutical industries. Its offerings include hard gelatin capsules, hydroxypropyl methylcellulose (HPMC) vegetarian capsules and others, including shiny capsules, sweet capsules, fast-release capsules, regulatory variants, sodium laureth sulfate (SLS) free capsules, preservative free capsules and transmissible spongiform encephalopathy (TSE) free capsules. The Company, through its subsidiary, Natural Biogenex Private Limited, is focused on manufacturing APIs such as prednisolone, betamethasone, dexamethasone, and hydrocortisone along with their derivatives. It has two manufacturing facilities that are located in Bengaluru and Puducherry.
Natural Capsules Share Price FAQs
Natural Capsules is trading at 214.55 as on Tue Jul 08 2025 10:17:32. This is -2.26% lower as compared to its previous closing price of 219.50.
The market capitalization of Natural Capsules is 221.26 Cr as on Tue Jul 08 2025 10:17:32.
The 52 wk high for Natural Capsules is 376.90 whereas the 52 wk low is 163.55
Natural Capsules can be analyzed on the following key metrics -
- TTM P/E: 657.96
- Sector P/E: 23.19
- Dividend Yield: 0.00%
- D/E ratio: 0.45
Natural Capsules reported a net profit of 0.62 Cr in 2025.
Quick Links